Atlanta, GA - Maintaining a lower hematocrit (HCT) can help reduce the risk of cardiovascular death in patients with polycythemia vera, according to the results of CYTO-PV [1]. Those who had an HCT of ...

Please provide your email address to receive an email when new articles are posted on . ATLANTA — The standard approach of maintaining hematocrit levels less than 45% in patients with polycythemia ...

ATLANTA -- Maintaining patients with polycythemia vera at hematocrit levels below 45% reduced thrombotic complications without increasing rates of other serious adverse events compared with a higher ...

According to Ira Zackon, MD, a hematologist-oncologist and senior medical director at Ontada, a retrospective study of over ...

Please provide your email address to receive an email when new articles are posted on . Induction therapy with twice-weekly rusfertide helped patients with polycythemia vera achieve target hematocrit ...

December 8, 2012 — Atlanta, GA — Maintaining a lower hematocrit (HCT) can help lower the risk for cardiovascular (CV) death in patients with polycythemia vera, according to the results of a new study.